291 related articles for article (PubMed ID: 22675625)
21. A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer.
Lucas AS; O'Neil BH; Goldberg RM
Clin Colorectal Cancer; 2011 Dec; 10(4):238-44. PubMed ID: 21820973
[TBL] [Abstract][Full Text] [Related]
22. [Target Therapy in Unresectable or Metastatic Colorectal Cancer].
Kim JH; Park SJ
Korean J Gastroenterol; 2016 Dec; 68(6):303-311. PubMed ID: 28025473
[TBL] [Abstract][Full Text] [Related]
23. Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.
Zarour LR; Anand S; Billingsley KG; Bisson WH; Cercek A; Clarke MF; Coussens LM; Gast CE; Geltzeiler CB; Hansen L; Kelley KA; Lopez CD; Rana SR; Ruhl R; Tsikitis VL; Vaccaro GM; Wong MH; Mayo SC
Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):163-173. PubMed ID: 28275683
[TBL] [Abstract][Full Text] [Related]
24. Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy.
Reddy N; Yu J; Fakih MG
Clin Colorectal Cancer; 2007 Jan; 6(5):362-6. PubMed ID: 17311701
[TBL] [Abstract][Full Text] [Related]
25. Molecular Genetics and the Role of Molecularly Targeted Agents in Metastatic Colorectal Carcinoma.
Naeem A; Tun AM; Guevara E
J Gastrointest Cancer; 2020 Jun; 51(2):387-400. PubMed ID: 31273629
[TBL] [Abstract][Full Text] [Related]
26. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
Bozec A; Peyrade F; Milano G
Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
[TBL] [Abstract][Full Text] [Related]
27. The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer.
Kim HJ; Lee SY; Oh SC
Front Physiol; 2016; 7():168. PubMed ID: 27242542
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
Biller LH; Schrag D
JAMA; 2021 Feb; 325(7):669-685. PubMed ID: 33591350
[TBL] [Abstract][Full Text] [Related]
30. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
Cercek A; Saltz LB
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
[TBL] [Abstract][Full Text] [Related]
31. Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy.
Nicolaides NC; O'Shannessy DJ; Albone E; Grasso L
Front Oncol; 2014; 4():141. PubMed ID: 24982846
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer.
Sur D; Lungulescu C; Dumitrescu EA; Afrăsânie V; Spînu Ș; Lungulescu CV; Schmoll HJ
Expert Rev Anticancer Ther; 2023 Jun; 23(6):633-641. PubMed ID: 37127555
[TBL] [Abstract][Full Text] [Related]
33. Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy.
Grivas P; Yu EY
Curr Treat Options Oncol; 2019 Jun; 20(8):67. PubMed ID: 31254108
[TBL] [Abstract][Full Text] [Related]
34. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
35. Emerging treatments in recurrent and metastatic colorectal cancer.
Ciombor KK; Bekaii-Saab T
J Natl Compr Canc Netw; 2013 Sep; 11 Suppl 4(Suppl 4):S18-27. PubMed ID: 24158967
[TBL] [Abstract][Full Text] [Related]
36. Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer.
Koukourakis GV; Sotiropoulou-Lontou A
Clin Transl Oncol; 2011 Oct; 13(10):710-4. PubMed ID: 21975331
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
Yu M; Grady WM
Therap Adv Gastroenterol; 2012 Sep; 5(5):319-37. PubMed ID: 22973417
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A
Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172
[TBL] [Abstract][Full Text] [Related]
39. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
[TBL] [Abstract][Full Text] [Related]
40. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
Berge E; Thompson C; Messersmith W
Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
